20 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Note: Treatment ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... itraconazolea 200 mg PO BID ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... 6.11.16,18,31,33,45,52,58) 0.5mL IM ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
suspension 400 mg PO BID ... mucosal #IDSA #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
consultation to guide management ... pallidum #IDSA #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
20 mg/kg IV or IM ... Leishmaniasis #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
should prevent the disease ... 500–1000 mg PO BID ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Recommendations for Preventing ... recommended for KS treatment ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
• Continue treatment ... HerpesSimplex #HSV #IDSA #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General Management ... IsosporaBelli #IDSA #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS